Results 101 to 110 of about 120,942 (241)

TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA. [PDF]

Acta Endocrinol (Buchar), 2023
Giraldi EA, Saindane A, Pradilla G, Biousse V, Ioachimescu AG.   +4 more
europepmc   +1 more source

A nanoluciferase complementation-based assay for monitoring β-arrestin2 recruitment to the dopamine D3 receptor

Biochemistry and Biophysics Reports
Luciferase complementation assays have emerged as a simple means of monitoring receptor-effector interactions in living cells in a time-resolved manner.
Viktor Burström, Kuiying Xu, Emilio Garro-Martínez, Robert H. Mach, Kristoffer Sahlholm, Nibal Betari   +5 more
doaj   +1 more source

A novel octopamine receptor with preferential expression in Drosophila mushroom bodies [PDF]

, 1998
Octopamine is a neuromodulator that mediates diverse physiological processes in invertebrates. In some insects, such as honeybees and fruit flies, octopamine has been shown to be a major stimulator of adenylyl cyclase and to function in associative ...
Han, K-A, Millar, NS
core  

Regulation of aromatic l‐amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists [PDF]

, 1994
Meng‐Yang Zhu, Augusto V. Juorio, I.A. Paterson, Alan A. Boulton   +3 more
openalex   +1 more source

Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia. [PDF]

Cell Rep Med, 2023
Abe Y, Yagishita S, Sano H, Sugiura Y, Dantsuji M, Suzuki T, Mochizuki A, Yoshimaru D, Hata J, Matsumoto M, Taira S, Takeuchi H, Okano H, Ohno N, Suematsu M, Inoue T, Nambu A, Watanabe M, Tanaka KF.   +18 more
europepmc   +1 more source

Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. [PDF]

Front Endocrinol (Lausanne), 2023
Wang L, Wang X, Gong F, Pan H, Zhu H.
europepmc   +1 more source

Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia. [PDF]

Mov Disord, 2023
Espa E, Song L, Skovgård K, Fanni S, Cenci MA.   +4 more
europepmc   +1 more source

The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D_4.4 receptor [PDF]

, 1998
Lucien Gazi, Ionel Bobirnac, M Danzeisen, E. Schüpbach, Anne T. Bruinvels, Sabine Geisse, Bernd Sommer, Daniël Hoyer, Mark D. Tricklebank, Philippe Schoeffter   +9 more
openalex   +1 more source

Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review. [PDF]

Cureus, 2023
Bazuhair T, Aleid B, Almalki M.
europepmc   +1 more source

Terguride—a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine

, 1988
E. Ciccarelli, R. Touzel, Michael Besser, A. Grossman   +3 more
openalex   +1 more source